can you take tirzepatide after semaglutide vs. for Weight Loss Tirzepatide as Compared with Semaglutide

One large observational study of 461,382 patients taking GLP-1 medications found that 15.1% developed vitamin deficiencies over 12 months, including 13.6% with vitamin D deficiency, 0.0% with niacin deficiency, and 0.1% with thiamine deficiency

Clinical trials show an average of 1517% body weight reduction over 68 weeks

Endotoxin contamination triggers inflammatory responses

Normally, it empties at a certain speed

the proportion with NASH resolution (ballooning 0, inflammation 0 or 1), without worsening of fibrosis and change in ALT.72 Phase IIB: Emricasan Emricasan is a pan-caspase inhibitor that has been shown to decrease portal hypertension by blocking apoptotic and inflammatory caspase activation involved in hepatocyte cell death.73 In a phase IIa study of patients with a baseline HVPG of 12 mmHg, patients treated with emricasan over 28 days had a 17.2% decrease in HVPG and a significant decrease in AST and ALT levels.74 These findings are being further explored in multiple phase IIb studies